Why the study?
Does cryoballoon catheter ablation improve outcomes in patients with symptomatic atrial fibrillation refractory or intolerant to antiarrhythmic medications?
Does cryoballoon catheter ablation improve outcomes in patients with symptomatic atrial fibrillation refractory or intolerant to antiarrhythmic medications?
This review summarizes the basics, clinical experience, safety, efficacy, and technical aspects of cryoballoon catheter ablation for atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Cryoballoon ablation remains an option for refractory AF; review extends technical knowledge but leaves open comparative RCTs.
Pulmonary vein isolation with catheter ablation is an effective treatment in patients with symptomatic atrial fibrillation refractory or intolerant to antiarrhythmic medications. The cryoballoon catheter was recently approved for this procedure. In this paper, the basics of cryothermal energy ablation are reviewed including its ability of creating homogenous lesion formation, minimal destruction to surrounding vasculature, preserved tissue integrity, and lower risk of thrombus formation. Also summarized here are the publications describing the clinical experience with the cryoballoon catheter ablation in both paroxysmal and persistent atrial fibrillation, its safety and efficacy, and discussions on the technical aspect of the cryoballoon ablation procedure.
No takes yet. Share an insight, caveat, or question.
Özcan et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: